Comparative Susceptibility of Pathogenic Methicillin-Resistant and Methicillin-Susceptible Staphylococcus pseudintermedius to Empirical Cotrimazole for Canine Pyoderma

The prevalence of methicillin-resistant (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this st...

Full description

Saved in:
Bibliographic Details
Published inLife (Basel, Switzerland) Vol. 13; no. 5; p. 1210
Main Authors Khongsri, Usasom, Chongrattanameteekul, Peerawit, Chantarachart, Sineenart, Photichai, Kornravee, Chanayat, Nittaya, Varinrak, Thanya, Mektrirat, Raktham, Srifawattana, Nuttawan
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 18.05.2023
MDPI
Subjects
Animals
Antimicrobial agents
Bacterial infections
Clinical medicine
Clinical trials
Dihydrofolate reductase
Dogs
Drug dosages
Drug resistance
Enzymes
Methicillin
Oxacillin
Pharmacokinetics
Pyoderma
Staphylococcus infections
Staphylococcus pseudintermedius
Susceptibility
Veterinary medicine
United Kingdom > UK
Thailand
United States > US
antimicrobial resistance
trimethoprim
methicillin
pharmacodynamics
sulfamethoxazole
staphylococci
pyoderma
Online AccessGet full text

Cover

Abstract The prevalence of methicillin-resistant (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this study was to evaluate the susceptibility of cotrimazole to canine pyoderma MRSP isolates. Sixty isolates of were identified as 16 MRSP and 44 methicillin-susceptible (MSSP) using an oxacillin disk diffusion test and VITEK 2 system with VITEK GP card. Using the VITEK 2 system with a VITEK AST-GP81 card, the susceptibility rates of MRSP (15.00%) and MSSP (35.00%) to cotrimazole was observed. The median MIC of cotrimazole on MSSP (median, ≤10; IQR, 10-320) was lower than that of MRSP (median, ≥320; IQR, 10-320) ( 0.5889, Mann-Whitney test). Percent attainment of PK/PD targets in MRSP (q 12 h, 43.75; q 8 h, 43.75) were lower than that of MSSP (q 12 h, 52.27; q 8 h, 52.27) ( = 0.7710). These findings show the moderately phenotypic cotrimazole susceptibilities of both MRSP and MSSP. Further study is required to develop clinical trials examining the use of cotrimazole in dogs with pyoderma.
AbstractList The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this study was to evaluate the susceptibility of cotrimazole to canine pyoderma MRSP isolates. Sixty isolates of S. pseudintermedius were identified as 16 MRSP and 44 methicillin-susceptible S. pseudintermedius (MSSP) using an oxacillin disk diffusion test and VITEK 2 system with VITEK GP card. Using the VITEK 2 system with a VITEK AST-GP81 card, the susceptibility rates of MRSP (15.00%) and MSSP (35.00%) to cotrimazole was observed. The median MIC of cotrimazole on MSSP (median, ≤10; IQR, 10-320) was lower than that of MRSP (median, ≥320; IQR, 10-320) (p = 0.5889, Mann-Whitney test). Percent attainment of PK/PD targets in MRSP (q 12 h, 43.75; q 8 h, 43.75) were lower than that of MSSP (q 12 h, 52.27; q 8 h, 52.27) (p = 0.7710). These findings show the moderately phenotypic cotrimazole susceptibilities of both MRSP and MSSP. Further study is required to develop clinical trials examining the use of cotrimazole in dogs with pyoderma.The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this study was to evaluate the susceptibility of cotrimazole to canine pyoderma MRSP isolates. Sixty isolates of S. pseudintermedius were identified as 16 MRSP and 44 methicillin-susceptible S. pseudintermedius (MSSP) using an oxacillin disk diffusion test and VITEK 2 system with VITEK GP card. Using the VITEK 2 system with a VITEK AST-GP81 card, the susceptibility rates of MRSP (15.00%) and MSSP (35.00%) to cotrimazole was observed. The median MIC of cotrimazole on MSSP (median, ≤10; IQR, 10-320) was lower than that of MRSP (median, ≥320; IQR, 10-320) (p = 0.5889, Mann-Whitney test). Percent attainment of PK/PD targets in MRSP (q 12 h, 43.75; q 8 h, 43.75) were lower than that of MSSP (q 12 h, 52.27; q 8 h, 52.27) (p = 0.7710). These findings show the moderately phenotypic cotrimazole susceptibilities of both MRSP and MSSP. Further study is required to develop clinical trials examining the use of cotrimazole in dogs with pyoderma.
The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this study was to evaluate the susceptibility of cotrimazole to canine pyoderma MRSP isolates. Sixty isolates of S. pseudintermedius were identified as 16 MRSP and 44 methicillin-susceptible S. pseudintermedius (MSSP) using an oxacillin disk diffusion test and VITEK 2 system with VITEK GP card. Using the VITEK 2 system with a VITEK AST-GP81 card, the susceptibility rates of MRSP (15.00%) and MSSP (35.00%) to cotrimazole was observed. The median MIC of cotrimazole on MSSP (median, ≤10; IQR, 10–320) was lower than that of MRSP (median, ≥320; IQR, 10–320) (p = 0.5889, Mann-Whitney test). Percent attainment of PK/PD targets in MRSP (q 12 h, 43.75; q 8 h, 43.75) were lower than that of MSSP (q 12 h, 52.27; q 8 h, 52.27) (p = 0.7710). These findings show the moderately phenotypic cotrimazole susceptibilities of both MRSP and MSSP. Further study is required to develop clinical trials examining the use of cotrimazole in dogs with pyoderma.
The prevalence of methicillin-resistant (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this study was to evaluate the susceptibility of cotrimazole to canine pyoderma MRSP isolates. Sixty isolates of were identified as 16 MRSP and 44 methicillin-susceptible (MSSP) using an oxacillin disk diffusion test and VITEK 2 system with VITEK GP card. Using the VITEK 2 system with a VITEK AST-GP81 card, the susceptibility rates of MRSP (15.00%) and MSSP (35.00%) to cotrimazole was observed. The median MIC of cotrimazole on MSSP (median, ≤10; IQR, 10-320) was lower than that of MRSP (median, ≥320; IQR, 10-320) ( 0.5889, Mann-Whitney test). Percent attainment of PK/PD targets in MRSP (q 12 h, 43.75; q 8 h, 43.75) were lower than that of MSSP (q 12 h, 52.27; q 8 h, 52.27) ( = 0.7710). These findings show the moderately phenotypic cotrimazole susceptibilities of both MRSP and MSSP. Further study is required to develop clinical trials examining the use of cotrimazole in dogs with pyoderma.
The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes. The empirical cotrimazole regimen remains interesting, but research on cotrimazole susceptibility to MRSP is limited. The objective of this study was to evaluate the susceptibility of cotrimazole to canine pyoderma MRSP isolates. Sixty isolates of S. pseudintermedius were identified as 16 MRSP and 44 methicillin-susceptible S. pseudintermedius (MSSP) using an oxacillin disk diffusion test and VITEK 2 system with VITEK GP card. Using the VITEK 2 system with a VITEK AST-GP81 card, the susceptibility rates of MRSP (15.00%) and MSSP (35.00%) to cotrimazole was observed. The median MIC of cotrimazole on MSSP (median, ≤10; IQR, 10–320) was lower than that of MRSP (median, ≥320; IQR, 10–320) ( p = 0.5889, Mann-Whitney test). Percent attainment of PK/PD targets in MRSP (q 12 h, 43.75; q 8 h, 43.75) were lower than that of MSSP (q 12 h, 52.27; q 8 h, 52.27) ( p = 0.7710). These findings show the moderately phenotypic cotrimazole susceptibilities of both MRSP and MSSP. Further study is required to develop clinical trials examining the use of cotrimazole in dogs with pyoderma.
Author Photichai, Kornravee
Srifawattana, Nuttawan
Chantarachart, Sineenart
Varinrak, Thanya
Mektrirat, Raktham
Khongsri, Usasom
Chanayat, Nittaya
Chongrattanameteekul, Peerawit
AuthorAffiliation 4 Epidemiological and Innovative Research Group for Infectious Diseases, Chiang Mai University, Chiang Mai 50200, Thailand
5 Research Center for Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand
3 Center of Veterinary Diagnosis and Technology Transfer, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand; kornravee.p@cmu.ac.th (K.P.); nittaya.cha@cmu.ac.th (N.C.); thanya.var@cmu.ac.th (T.V.)
1 Department of Veterinary Biosciences and Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand; usasom.khongs@cmu.ac.th (U.K.); peerawit_ch@cmu.ac.th (P.C.)
2 Small Animal Hospital, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; sineenart.ch@cmu.ac.th
AuthorAffiliation_xml – name: 3 Center of Veterinary Diagnosis and Technology Transfer, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand; kornravee.p@cmu.ac.th (K.P.); nittaya.cha@cmu.ac.th (N.C.); thanya.var@cmu.ac.th (T.V.)
– name: 2 Small Animal Hospital, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; sineenart.ch@cmu.ac.th
– name: 1 Department of Veterinary Biosciences and Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand; usasom.khongs@cmu.ac.th (U.K.); peerawit_ch@cmu.ac.th (P.C.)
– name: 5 Research Center for Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand
– name: 4 Epidemiological and Innovative Research Group for Infectious Diseases, Chiang Mai University, Chiang Mai 50200, Thailand
Author_xml – sequence: 1
  givenname: Usasom
  surname: Khongsri
  fullname: Khongsri, Usasom
  organization: Small Animal Hospital, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
– sequence: 2
  givenname: Peerawit
  orcidid: 0009-0009-6690-0232
  surname: Chongrattanameteekul
  fullname: Chongrattanameteekul, Peerawit
  organization: Department of Veterinary Biosciences and Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
– sequence: 3
  givenname: Sineenart
  surname: Chantarachart
  fullname: Chantarachart, Sineenart
  organization: Small Animal Hospital, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
– sequence: 4
  givenname: Kornravee
  surname: Photichai
  fullname: Photichai, Kornravee
  organization: Center of Veterinary Diagnosis and Technology Transfer, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
– sequence: 5
  givenname: Nittaya
  surname: Chanayat
  fullname: Chanayat, Nittaya
  organization: Center of Veterinary Diagnosis and Technology Transfer, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
– sequence: 6
  givenname: Thanya
  surname: Varinrak
  fullname: Varinrak, Thanya
  organization: Center of Veterinary Diagnosis and Technology Transfer, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand
– sequence: 7
  givenname: Raktham
  orcidid: 0000-0001-7429-0993
  surname: Mektrirat
  fullname: Mektrirat, Raktham
  organization: Research Center for Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand
– sequence: 8
  givenname: Nuttawan
  surname: Srifawattana
  fullname: Srifawattana, Nuttawan
  organization: Small Animal Hospital, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37240855$$D View this record in MEDLINE/PubMed
BookMark eNpdkctu1TAQhi1URC90xxpZYsMm4Euc2CuEokKRiqi4rKOJ4_RM5dghdiodXojXxBWlapmNRzP_fPPbPiYHIQZHyAvO3khp2FuPk-OSKS44e0KOBGtVxVthDh7kh-Q0pWtWolG80fUzcihbUTOt1BH53cV5gRUy3jj6bUvWLRkH9Jj3NE70EvIuXrmAln52eYcWvcdQfXUJU4aQKYTxUece4Qsuw7Lb-2ijtVuiS3LbiCG7dXYjlkKO9GxecEULnnYxrzjDr1gGp7jSDgIGRy_3cSwD8Jw8ncAnd3p3npAfH86-d-fVxZePn7r3F9UijMqV49pqLYxlI2taPjDN2QhGuRbaSZl2MFKIGqbagNGjlG7ghtUw6nESik1MnpB3f7nLNhSb1oW8gu-XW2_rvo-A_eNOwF1_FW96zoTgqhWF8PqOsMafm0u5n7G8ifcQXNxSL7RgTNSNul326j_pddzWUO5XVNzUjdS6LqqXDy3de_n3ifIPhNymOQ
ContentType Journal Article
Copyright 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID NPM
8FD
8FE
8FH
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PATMY
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PYCSY
RC3
7X8
5PM
DOI 10.3390/life13051210
DatabaseName PubMed
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
Biotechnology and BioEngineering Abstracts
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Genetics Abstracts
Natural Science Collection
ProQuest Central Korea
Agricultural & Environmental Science Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
ProQuest One Academic UKI Edition
Environmental Science Database
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Veterinary Medicine
EISSN 2075-1729
ExternalDocumentID PMC10221572
37240855
Genre Journal Article
GeographicLocations United Kingdom--UK
Thailand
United States--US
GeographicLocations_xml – name: United Kingdom--UK
– name: Thailand
– name: United States--US
GrantInformation_xml – fundername: Faculty of Veterinary Medicine, Chiang Mai University
  grantid: R000028480
GroupedDBID 53G
5VS
7XC
8FE
8FH
AADQD
AAFWJ
ABDBF
ACUHS
ADBBV
AEUYN
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
DIK
ESX
GROUPED_DOAJ
HCIFZ
HYE
IAO
IEP
ISR
ITC
KQ8
LK8
M48
M7P
MODMG
M~E
NPM
OK1
PATMY
PGMZT
PIMPY
PROAC
PYCSY
RPM
8FD
ABUWG
AZQEC
DWQXO
FR3
GNUQQ
P64
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
ID FETCH-LOGICAL-p295t-e18c8829c0d0671b0810da95e7a7f597b93224af49a98d33eb1904ad8df250f03
IEDL.DBID M48
ISSN 2075-1729
IngestDate Thu Aug 21 18:37:53 EDT 2025
Fri Jul 11 02:23:46 EDT 2025
Fri Jul 25 10:27:00 EDT 2025
Wed Feb 19 02:23:55 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords antimicrobial resistance
trimethoprim
methicillin
pharmacodynamics
sulfamethoxazole
staphylococci
pyoderma
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p295t-e18c8829c0d0671b0810da95e7a7f597b93224af49a98d33eb1904ad8df250f03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7429-0993
0009-0009-6690-0232
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/life13051210
PMID 37240855
PQID 2819463884
PQPubID 2032373
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10221572
proquest_miscellaneous_2820024650
proquest_journals_2819463884
pubmed_primary_37240855
PublicationCentury 2000
PublicationDate 2023-05-18
PublicationDateYYYYMMDD 2023-05-18
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-18
  day: 18
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Life (Basel, Switzerland)
PublicationTitleAlternate Life (Basel)
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
SSID ssj0000651684
Score 2.2701652
Snippet The prevalence of methicillin-resistant (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance studies, with annual changes....
The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance...
The prevalence of methicillin-resistant Staphylococcus pseudintermedius (MRSP) that causes pyoderma has been gradually shifting, according to many surveillance...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1210
SubjectTerms Animals
Antimicrobial agents
Bacterial infections
Clinical medicine
Clinical trials
Dihydrofolate reductase
Dogs
Drug dosages
Drug resistance
Enzymes
Methicillin
Oxacillin
Pharmacokinetics
Pyoderma
Staphylococcus infections
Staphylococcus pseudintermedius
Susceptibility
Veterinary medicine
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9swED6xIqS9TKywrRtDRtprRNI4tfOERlWEJoEqGIi3yvEPrRLYGUkeun9o_yZ3SSjrNO01jqNIZ9995_v8HcAXgyFJWIfZiXE64il3keQ2jmzmYitEobigy8kXl5PzG_7tLrvrD9yqnlb57BNbR22CpjPyYyr4cFwskp-UPyPqGkXV1b6FxivYRhcs5QC2T2eX86v1KQsG2GQiecd4TzG_P75fOot-OyPhrH-hyr_JkX9Em7NdeNPDRPa1s-tb2LJ-CDtd48jVEIa3xGJpr9Kyi746vge_py9S3uy6qVrGSkt-XbHg2BzBXsD1stQ4h2judNTioytbEYb0NVPebIysP3GPn6tJ2BojX9C6qVhZ2caQ1MQjFefxQR3Y7KFctoIjbBpqErH4FXAigmI2VR5_kM1X1HjtQe3Dzdns-_Q86hsxROU4z-rIJlIjEs91bDC4JQXCiNioPLNCCYcZSYEgcMyV47nKpUlT9P95zJWRxiHCcnH6DgY-ePsBmJCpMQ73PWZ6XGvM10SBXiPVQmNcnLgRHDybZNHvpmrxYvsRHK2HcR9QcUN5Gxp6h-gmHAHnCN53FlyUnWDHIhWtkFs2Arlh2_ULpLG9OeKXP1qtbUqIk0yMP_7_vz7Ba-pDT7SCRB7AoH5s7GdEK3Vx2C_JJ9ew8tc
  priority: 102
  providerName: ProQuest
Title Comparative Susceptibility of Pathogenic Methicillin-Resistant and Methicillin-Susceptible Staphylococcus pseudintermedius to Empirical Cotrimazole for Canine Pyoderma
URI https://www.ncbi.nlm.nih.gov/pubmed/37240855
https://www.proquest.com/docview/2819463884
https://www.proquest.com/docview/2820024650
https://pubmed.ncbi.nlm.nih.gov/PMC10221572
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB5RUCsuCPoM0GgrcTXY8Tq7PlSojYIQUlBEicQtWu9DRArrNLalhj_E3-yMnaSk5dSr93HY2Z35vt3xNwAnBkOSsA7ZiXE64DF3geQ2DGziQitEprign5MH193LEb-6S-62YFVtdLmAxYvUjupJjebT018_F-d44L8S40TKfjadOIuuOCEtrFewgzFJUC2DwRLoNz45ibqSN5nv_wzahTexqLW-kpeA5t_5ks8C0MU-7C2RI_vWmPoAtqx_C6-bWpKLd_DU-6PjzX5URZ2uUme-Llju2BCRXo6bZaLZwFKOO92z-ODGFgQgfcmUNxst6ymmOF1JqtYY9nKtq4LNClsZ0pmY08s8fihz1n-YTWq1EdbLS1KweMxxICJi1lMekSwbLqjq2oN6D6OL_m3vMlhWYQhmnTQpAxtJjTA81aHByBZliCFCo9LECiUc0pEMEWCHK8dTlUoTx-j805ArI41DeOXC-ANs-9zbT8CEjI1xeOiR5nGtkayJDF1GrIXGoNh1LTheLf54tRPG9NLH0UtI3oIv62Y8BPSyobzNK-pDuSYc0WYLPja2Gs8atY7xyrItkBtWXHcgge3NFj-5r4W2iQ1Hiegc_v_QI9ilAvWUbxDJY9gu55X9jDCmzNqw871_Pbxp19cA7Xq__gYj-fxg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9NAEB2VVIheEISvQIFFgqNV27vO2geEIKRKaRNFpUW9GXs_RKTWdmtbKPwhbvxGZmwnJQhx69VrryzN7Myb3bdvAF5rTEnSWKxOtFWO4MI6oTCuYwLrGinTREi6nDydDSen4tNZcLYFv1Z3YYhWuYqJTaDWuaI98j068BHoLKF4V1w61DWKTldXLTRatzg0y-9YspVvDz6ifd_4_v74ZDRxuq4CTuFHQeUYL1QIKyPlaozUXoo50dVJFBiZSIvwOkVE44vEiiiJQs05BrPIFYkOtUW4YF2O896CbcGHrt-D7Q_j2fx4vauDCd0bhqJl2HMeuXvnC2swTwQk1PUvFPs3GfOP7LZ_D-52sJS9b_3oPmyZrA-320aVyz70vxBrprm6y6bdafwD-Dm6lg5nn-uyYcg0ZNslyy2bI7jM0T8XCr8hWj1t7WTOsSkJs2YVSzK9MbKe4hynq0hIGzNtrlRdsqI0tSZpiysiA-CDKmfji2LRCJywUV6RaMaPHD9EEM5GSYY_yOZLavR2kTyE0xsx0SPoZXlmngCTIdfaYpzBylIohfWhTDFKcSUV5uGhHcDuyiRxt3rL-NrXBvBqPYzrjg5TkszkNb1D9BaBAHcAj1sLxkUrEBJz2QjHBQMIN2y7foE0vTdHssW3RtubCnAvkP7T___XS7gzOZkexUcHs8NnsOMj8iJKgxfuQq-6qs1zREpV-qJzTwZfb3pF_AZ8cC77
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVCBeEIRbSoFFgkcrvqyz9gNCkCZqKY2iQlHf3PVeRKTWdmtbKPwQ_8DXMWM7KUGIt7567ZWlmZ05s3v2DMBrjSlJGIvVibbK4QG3TsSN65jQukaIVHJBl5OPZqP9E_7xNDzdgl-ruzBEq1zFxCZQ61zRHvmQDnw4OkvEh7ajRcz3pu-KS4c6SNFJ66qdRusih2b5Hcu38u3BHtr6je9PJ1_G-07XYcAp_DisHONFCiFmrFyNUdtLMT-6WsahEVJYhNopohufS8tjGUc6CDCwxS6XOtIWoYN1A5z3FmwLqop6sP1hMpsfr3d4MLl7o4i3bPsgiN3h-cIazBkhiXb9C9H-Tcz8I9NN78O9DqKy961PPYAtk_Xhdtu0ctmH_ldi0DTXeNlRdzL_EH6Or2XE2ee6bNgyDfF2yXLL5gg0c_TVhcJviGJP2zyZc2xKwq9ZxWSmN0bWU5zjdBWJamPWzZWqS1aUptYkc3FFxAB8UOVsclEsGrETNs4rEtD4keOHCMjZWGb4g2y-pKZvF_IRnNyIiR5DL8sz8xSYiAKtLcYcrDK5UlgrihQjVqCEwpw8sgPYXZkk6VZymVz73QBerYdxDdLBisxMXtM7RHXhCHYH8KS1YFK0YiFJIBoRuXAA0YZt1y-QvvfmSLb41uh8UzHuhcLf-f9_vYQ7uBKSTwezw2dw10cQRuwGL9qFXnVVm-cImqr0ReedDM5uekH8BgdIMzA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+Susceptibility+of+Pathogenic+Methicillin-Resistant+and+Methicillin-Susceptible+Staphylococcus+pseudintermedius+to+Empirical+Cotrimazole+for+Canine+Pyoderma&rft.jtitle=Life+%28Basel%2C+Switzerland%29&rft.au=Khongsri%2C+Usasom&rft.au=Chongrattanameteekul%2C+Peerawit&rft.au=Chantarachart%2C+Sineenart&rft.au=Photichai%2C+Kornravee&rft.date=2023-05-18&rft.pub=MDPI&rft.eissn=2075-1729&rft.volume=13&rft.issue=5&rft_id=info:doi/10.3390%2Flife13051210&rft_id=info%3Apmid%2F37240855&rft.externalDocID=PMC10221572
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2075-1729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2075-1729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2075-1729&client=summon